作者：
James,Larkin [1]
;
Mototsugu,Oya [2]
;
Marcella,Martignoni [3]
;
Fiona,Thistlethwaite [4]
;
Paul,Nathan [5]
;
Moshe C,Ornstein [6]
;
Thomas,Powles [7]
;
Kathryn E,Beckermann [8]
;
Arjun V,Balar [9]
;
David,McDermott [10]
;
Sumati,Gupta [11]
;
George K,Philips [12]
;
Michael S,Gordon [13]
;
Hirotsugu,Uemura [14]
;
Yoshihiko,Tomita [15]
;
Jing,Wang [16]
;
Elisabete,Michelon [17]
;
Alessandra,di Pietro [18]
;
Toni K,Choueiri [19]
作者单位：
Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.
[1]
Department of Urology, Keio University Hospital, Tokyo, Japan.
[2]
Clinical Development and Operations, Pfizer, Milan, Italy.
[3]
The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
[4]
Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
[5]
Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
[6]
Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St Bartholomew's Hospital, London, UK.
[7]
Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
[8]
Department of Medicine, Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA.
[9]
Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[10]
Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
[11]
Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
[12]
Division of Cancer Research, HonorHealth Research Institute, Scottsdale, AZ, USA.
[13]
Department of Medicine, Kindai University Hospital, Osaka, Japan.
[14]
Department of Urology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
[15]
Biostatistics, Pfizer, Cambridge, MA, USA.
[16]
Safety Surveillance & Risk Management, New York, NY, USA.
[17]
Global Product Development, Pfizer, Milan, Italy.
[18]
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
[19]
DOI
10.1093/oncolo/oyac243
PMID
36576173
发布时间
2023-04-26
换一批
换一批
